Bunevicius A, Iervasi G, Bunevicius R. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Review of Neurotherapeutics. 2015;15(3):315 - 326. 

Sabatino L, Lubrano V, Balzan S, Kusmic C, Del Turco S, Iervasi G. Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones. Molecular and Cellular Biochemistry. 2015;399(1-2):87 - 94. 

Sabatino L, Iervasi G, Pingitore A. Thyroid hormone and heart failure: from myocardial protection to systemic regulation. Expert Review of Cardiovascular Therapy. 2014;12(10):1227 - 1236. 

Balzan S, Del Carratore R, Nicolini G, Beffy P, Lubrano V, Forini F, Iervasi G. Proangiogenic Effect of TSH in Human Microvascular Endothelial Cells through Its Membrane Receptor. The Journal of Clinical Endocrinology & Metabolism. 2012;97(5):1763 - 1770. 

Pingitore A, Landi P, Taddei MChiara, Ripoli A, L?Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. The American Journal of Medicine [Internet]. 2005;118(2):132 - 136. http://linkinghub.elsevier.com/retrieve/pii/S0002934304006576

Sabatino L, Chopra IJ, Tanavoli S, Iacconi P, Iervasi G. A Radioimmunoassay for Type I Iodothyronine 5'-Monodeiodinase in Human Tissues. Thyroid. 2001;11(8):733 - 739. 

Sabatino L, Iervasi G, Ferrazzi P, Francesconi D, Chopra IJ. A study of iodothyronine 5?-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues. Life Sciences. 2000;68(2):191 - 202.